跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NEUROFIND PROLONGED RELEASE TABLETS 36 MG - HSA Drug Approval Details
Approvals
/
HSA
/
NEUROFIND PROLONGED RELEASE TABLETS 36 MG
Approved
STANDARD
NEUROFIND PROLONGED RELEASE TABLETS 36 MG
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
e07b02350fc9dae1
Company
Unknown
Type
Standard
Approval Details
Approval Id
e07b02350fc9dae1
Drug Name
NEUROFIND PROLONGED RELEASE TABLETS 36 MG
Active Ingredients
Methylphenidate Hydrochloride
36 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
e07b02350fc9dae1
Type
Standard
Back to HSA Approvals